IQVIA (NYSE:IQV) Price Target Lowered to $239.00 at JPMorgan Chase & Co.

IQVIA (NYSE:IQV – Free Report) had its target price reduced by JPMorgan Chase & Co. from $262.00 to $239.00 in a report released on Monday, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the medical research company’s stock. Several other analysts have also commented on the stock. Robert W. Baird lowered […]

Leave a Reply

Your email address will not be published.

Previous post HC Wainwright Cuts Oncolytics Biotech (NASDAQ:ONCY) Price Target to $5.00
Next post Ravens TE Mark Andrews likely suffered season-ending ankle injury vs. Bengals: ‘It’s devastating’